DeepHealth, a wholly-owned subsidiary of RadNet (RDNT), has received expanded FDA 510(k) clearance for its mammography software. SmartMammo Dx, the AI algorithm within SmartMammo, is now FDA-cleared to be compatible with GE HealthCare’s (GEHC) Senographe Pristina mammography systems. SmartMammo Dx was first cleared in May 2021 in conjunction with Hologic mammography systems, where its performance has also been tested and cleared in patients with unilateral breasts and with breast implants. “This newly expanded clearance advances DeepHealth’s mission to enhance and expand breast cancer screening programs by broadening system compatibility,” the company stated.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RDNT: